The firm expects a promising treatment for acute leukemia could drive upside for the stock.
You are here: Home / This little-known pharma stock can rally more than 60% in 2023, JPMorgan says
Market News and Views
The firm expects a promising treatment for acute leukemia could drive upside for the stock.